Scott E Nelson

6PUBLICATIONS
23CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursBiomaterialsMechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 26, 2026
Epstein-Barr virus (EBV) infection causes human germinal center B cell-derived lymphomas in the absence of EBNA2 expression.

|May 08, 2023
Epstein-Barr virus LMP1 protein promotes proliferation and inhibits differentiation of epithelial cells via activation of YAP and TAZ.

Deo R Singh, Scott E Nelson, Abigail S Pawelski

|Apr 26, 2022
Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells.

Jillian A Bristol, Joshua Brand, Makoto Ohashi

|Aug 02, 2021
Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells.

Nicholas Van Sciver, Makoto Ohashi, Nicholas P Pauly

|Jun 17, 2020
EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.

Chunrong Li, James C Romero-Masters, Shane Huebner

|Feb 15, 2020
B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection.

James C Romero-Masters, Shane M Huebner, Makoto Ohashi

Pageof 1

Frequent Collaborators

5 joint publications

Jillian A Bristol

5 joint publications

Shannon C Kenney

3 joint publications

James C Romero-Masters

3 joint publications

Jenny Gumperz